AssetMark Inc
TXMD icon

AssetMark Inc’s TherapeuticsMD TXMD Stock Holding History

AssetMark Inc’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8 Hold
4
– – ﹤0.01% 3431
2025
Q4 		$7 Hold
4
– – ﹤0.01% 3365
2025
Q3 		$4 Hold
4
– – ﹤0.01% 3178
2025
Q2 		$5 Hold
4
– – ﹤0.01% 2997
2025
Q1 		$4 Hold
4
– – ﹤0.01% 2617
2024
Q4 		$3 Hold
4
– – ﹤0.01% 2588
2024
Q3 		$7 Buy
+4
New +$7 ﹤0.01% 2244
2024
Q2 		– Sell
-1
Closed -$2 – 2233
2024
Q1 		$2 Buy
+1
New +$2 ﹤0.01% 1930

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AssetMark Inc's TXMD Position: Q1 2026 in Review

AssetMark Inc held its TherapeuticsMD (TXMD) position steady in Q1 2026 at 4 shares worth $8. The position accounts for ﹤0.01% of the portfolio, ranked #3431.

AssetMark Inc first reported a position in TXMD in Q1 2024 and has held it in 8 quarters since. 49 funds tracked by Wall St. Rank hold TXMD as of Q1 2026.

  • AssetMark Inc held 4 shares of TherapeuticsMD worth $8 as of Q1 2026.
  • AssetMark Inc left its TherapeuticsMD share count unchanged in Q1 2026.
  • TherapeuticsMD made up ﹤0.01% of AssetMark Inc's portfolio in Q1 2026, its #3431 holding.
  • AssetMark Inc first reported a position in TherapeuticsMD in Q1 2024 and has held it in 8 quarters since.
  • 49 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2026.

Based on AssetMark Inc's 13F filing for Q1 2026, filed 6 May 2026.